Detalles de la búsqueda
1.
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.
N Engl J Med
; 375(6): 545-55, 2016 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27509102
2.
Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study.
Genet Med
; 21(9): 1987-1997, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30723321
3.
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.
J Med Genet
; 54(4): 288-296, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27834756
4.
An analysis of the impact of FDA's guidelines for addressing cardiovascular risk of drugs for type 2 diabetes on clinical development.
Contemp Clin Trials
; 32(3): 324-32, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21266202
5.
An analysis of current pharmaceutical industry practices for making clinical trial results publicly accessible.
Contemp Clin Trials
; 30(4): 293-9, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19348964
Resultados
1 -
5
de 5
1
Próxima >
>>